Clinical trial
Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease…
NCT00291720 · University Hospital Birmingham, Other · Completed
Key facts
| NCT number | NCT00291720 |
|---|---|
| Title | Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure? |
| Official title | Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure? |
| Lead sponsor | University Hospital Birmingham, Other |
| Collaborators | British Heart Foundation |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Kidney Disease, Cardiovascular Disease |
| Intervention type | Drug |
| Interventions | Spironolactone, Placebo |
| Enrollment | 120 |
| Start date | Apr 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Feb 14, 2006 |
| Last update posted | May 21, 2008 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: